- 38 次围观
产品图片

货号/SKU
NR-52194
货号/规格
EA
库存与交货期
3-8周
人民币价格
14000
试剂海关审批
A/B级风险物质只能直接使用人购买并持有实验室有效资质,其它询客服确认
国外采购
支持/部分限制一年内购买数量
厂牌
BEI Resources(ATCC)
产品基础信息
生物安全等级建议分类:美国、2
产品描述信息
NR-52194??Acinetobacter baumannii, MRSN 15049(Bacteria)|Acinetobacter baumannii|MRSN 15049|-60°C or colder|MRSN/WRAIRAcknowledgment for publications should read “The following reagent was obtained through BEI Resources, NIAID, NIH: Acinetobacter baumannii, Strain MRSN 15049, NR-52194. This strain is part of the Acinetobacter baumannii Diversity Panel provided by the Multidrug-Resistant Organism Repository and Surveillance Network (MRSN) at the Walter Reed Army Institute of Research (WRAIR).”|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.
Acinetobacter baumannii (A. baumannii), strain MRSN 15049 was isolated in 2013 from a respiratory specimen in Asia as part of a global surveillance program.
A. baumannii, strain MRSN 15049 was deposited as part of the MRSN Acinetobacter baumannii Diversity Panel available from BEI Resources as NR-52248. NR-52194 was deposited as multi-locus sequence type (MLST) ST 1, sensitive to colistin and tobramycin, resistant to amikacin, cefepime, ceftazidime, ceftriaxone, ciprofloxacin, gentamicin, imipenem, levofloxacin, meropenem, trimethoprim/sulfamethoxazole and tetracycline, and intermediately resistant to ampicillin/sulbactam. Strain MRSN 15049 is reported to have three aminoglycoside transferase genes [aph(3’)-1b, aph(3’)-VI and aph(6)-1d; conferring resistance to various aminoglycosides], three beta-lactamase genes (blaADC-25, blaOXA-23 and blaOXA-371; conferring resistance to beta-lactams) and a sulfonamide resistance gene (sul2; conferring resistance to sulfonamides). The complete genome of A. baumannii, strain MRSN 15049 is available (GenBank: VHGW00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
Acinetobacter baumannii (A. baumannii), strain MRSN 15049 was isolated in 2013 from a respiratory specimen in Asia as part of a global surveillance program.
A. baumannii, strain MRSN 15049 was deposited as part of the MRSN Acinetobacter baumannii Diversity Panel available from BEI Resources as NR-52248. NR-52194 was deposited as multi-locus sequence type (MLST) ST 1, sensitive to colistin and tobramycin, resistant to amikacin, cefepime, ceftazidime, ceftriaxone, ciprofloxacin, gentamicin, imipenem, levofloxacin, meropenem, trimethoprim/sulfamethoxazole and tetracycline, and intermediately resistant to ampicillin/sulbactam. Strain MRSN 15049 is reported to have three aminoglycoside transferase genes [aph(3’)-1b, aph(3’)-VI and aph(6)-1d; conferring resistance to various aminoglycosides], three beta-lactamase genes (blaADC-25, blaOXA-23 and blaOXA-371; conferring resistance to beta-lactams) and a sulfonamide resistance gene (sul2; conferring resistance to sulfonamides). The complete genome of A. baumannii, strain MRSN 15049 is available (GenBank: VHGW00000000).
Each vial contains approximately 0.5 mL of bacterial culture in Tryptic Soy broth supplemented with 10% glycerol.
Additional information and tools are available at PATRIC (Pathosystems Resource Integration Center).
主要内容
此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到NIAID批准.
AcineTobacter Baumannii(A.Baumannii),菌株MRSN 15049于2013年从亚洲的呼吸标本中分离,作为全球监测计划的一部分.
a. Baumannii ,菌株MRSN 15049作为MRSN 的一部分沉积,从BAUMANNII(FEI资源)作为NR-52248获得的多样性面板. NR-52194被沉积为多基因座序列(MLST)ST1,对Colistin和Tabramycin敏感,耐阿里卡辛,头孢酮,头孢他啶,头孢曲松,环丙沙星,庆大霉素,Imipenem,左氧氟沙星,梅洛涅伦姆,三甲双胍/磺胺嘧啶和四环素,以及四环素中间耐氨苄青霉素/苏酰胺.据报道,菌株MRSN 15049具有三种氨基糖苷类转移酶[(3') - 1B, APH (3') - VI和 APH (6)-1d;赋予各种氨基糖苷的耐药性,三种β-内酰胺酶基因( BLA ADC-25 , BLA Oxa-23 和 Bla oxa-371 ;赋予β-内酰胺的耐药性)和磺酰胺抗性基因( sul 2;赋予硫磺酰胺抗性). a的完整基因组. Baumannii ,菌株MRSN 15049可用(Genbank:).
每个小瓶含有约0.5ml的胰蛋白酶肉汤中的细菌培养,补充有10%甘油.
patric (Pathosystems资源集成中心)提供了其他信息和工具.
厂牌介绍
BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立,旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中,可以监控科学界对这些材料的访问和使用,并确保试剂的质量控制。
除了为传染病界提供材料外,BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势,包括安全存储、社区访问和分发;同时保护存款人的知识产权。只要有需要,BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。
BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月, ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料,包括由其他政府支持的研究项目存放的材料,将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中,涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。
品牌标识

可能感兴趣的内容
2021-12-02
2022-04-01
2022-06-17
2022-04-01
2024-10-16
2025-04-19
2022-04-01
2022-04-01
2022-04-01
2021-12-21
2022-04-01
2021-12-21